During the development of TP-102 a lot of journals published pieces describing this great Technophage’s milestone. This year, Jornal Expresso, described the efforts made by the company to reach Phase I/IIa Clinical Trial with TP-102 in Israel. If you did not get a chance to read, take now the time to accompany us as we get closer to the next steps.

To read the entire piece click here.